- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05152836
The Effect of Vibrotactile Stimulation on Parkinson's Tremor
The Effect of Vibrotractile Stimulation on Parkinson's Tremor - an Explorative Study
Study Overview
Status
Conditions
Detailed Description
Parkinson's disease (PD) is the second most common neurodegenerative disease, of which tremor is a common and highly burdensome symptom. The pathophysiology of tremor involves a cerebral network that consists of basal ganglia and a cerebello-thalamo-cortical motor circuit. Emerging evidence suggests that somatosensory input from the tremulous limb to the brain may influence this network. Specifically, tremor-related activity was observed in primary and secondary somatosensory cortex, and thalamic cells involved in tremor appear to be responsive to somatosensory stimulation as well. Somatosensory afferents may thus play a role in tremor pathophysiology and could therefore be used as treatment target. Here, the investigators will test this hypothesis by investigating the effect of modulating somatosensory input (with vibrotactile stimulation) on tremor severity.
The primary objectives are 1) to test whether rhythmic somatosensory input (vibrotactile stimulation) at tremor frequency reduces tremor power of Parkinson's tremor as compared to vibrotactile stimulation at 1.5 times tremor frequency and 2) whether continuous 80Hz vibrotactile stimulation reduces tremor power as compared to sham stimulation. As secondary objectives, the investigators will test whether the effect of vibrotactile stimulation on tremor power depends on the context in which tremor occurs (rest, cognitive coactivation, posture), whether stimulation at tremor frequency reduces tremor power as compared to sham stimulation, and whether vibrotactile stimulation has an effect on two other common PD symptoms: impaired gait and bradykinesia. The investigators will include 27 patients with Parkinson's disease and rest as well as postural tremor. The intervention involves subtle mechanical vibrations on the wrist or ankles. This is a non-invasive and painless way to provide somatosensory stimuli, in a continuous (80Hz) or rhythmic fashion (brief bursts of 80 Hz at tremor or step frequency).
The investigators expect that this study will provide mechanistic insights into if and how somatosensory (vibro-tactile) afferents influence the cerebral tremor circuit in Parkinson's disease, and may provide a solid basis for designing further clinical treatment studies.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6500HB
- Donders Centre for Cognitive Neuroimaging
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18-80 years old and able to provide informed consent
- Have a diagnosis of idiopathic PD made by a movement disorders specialist
- Medically optimized without planned medication changes for the duration of the study • Resting tremor subscore >/= 2 of the most-affected arm on the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) item 2.10
- Postural tremor subscore >/= 1 of the most-affected arm on the MDS-UPDRS item 3.15
- Signed informed consent
Exclusion Criteria:
- The presence of additional neurologic diseases that might confound testing or the coexistence of PD and essential tremor together (action tremor that was present prior to the development of parkinsonism)
- Moderate to severe peripheral neuropathy (reduced vibratory sensation) at the upper extremities, quantified with a graduated tuning fork
- Montreal cognitive assessment (MoCA) score < 20 or previously documented dementia
- Unable to walk without walking aid
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vibrotactile stimulation atdifferent settings
All participants receive vibrotactile stimulation at three different stimulation settings as well as one sham condition.
Specifically, stimulation is applied at (1) brief bursts of 80Hz that occur at the individual tremor frequency, (2) 80Hz bursts at tremor frequency*1.5, and (3) continuous stimulation at 80Hz.
The sham condition does not involve any stimulation.
All of the stimulations will be applied under three different contextual manipulations: during rest, posture and cognitive coactivation (serial subtraction task).
Within each context, stimulation/sham conditions are applied in random order.
|
Mechanical vibrations are applied at brief bursts of 80Hz that occur at the individual tremor frequency.
Vibrations are delivered via a small device, which is worn on the wrist of the most-affected arm.
Mechanical vibrations are applied at 80Hz bursts at individual tremor frequency*1.5.
Vibrations are delivered via a small device, which is worn on the wrist of the most-affected arm.
Continuous 80Hz stimulation is applied via a small device worn on the wrist of the most-affected arm.
This intervention is applied during assessment of gait.
Two devices are worn on both ankles which allows alternating stimulation of both ankles with brief bursts of 80 HZ at the individual step frequency plus or minus 10%.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of vibrotactile stimulation at tremor frequency on tremor severity with active control
Time Frame: 25 minutes
|
The investigators will investigate the effect of frequency specific stimulation compared to an active control condition, averaged across three different contexts (rest/posture/cognitive coactivation).
Specifically, we will test the change in log transformed tremor power from baseline to stimulation, as a function of stimulation setting (bursts at tremor frequency vs. bursts at 1.5 times tremor frequency).
|
25 minutes
|
The effect of continuous vibrotactile stimulation on tremor severity
Time Frame: 25 minutes
|
The investigators will investigate the effect of continuous stimulation compared to sham stimulation, averaged across three different contexts (rest/posture/cognitive coactivation).
Specifically, we will test the change in log transformed tremor power from baseline to stimulation, as a function of stimulation setting (continuous 80Hz stimulation vs. sham).
For the two primary outcomes measures, Bonferroni correction will be applied to correct for multiple comparisons.
|
25 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of vibrotactile stimulation at tremor frequency on tremor severity with passive control
Time Frame: 25 minutes
|
The investigators will explore the change in log transformed tremor power from baseline to stimulation, as a function of stimulation setting (bursts at tremor frequency vs. sham).
|
25 minutes
|
The effect of continuous vibrotactile stimulation on bradykinesia
Time Frame: 10 minutes
|
The average button presses per second in the keyboard finger tapping test during continuous 80Hz stimulation versus sham will be investigated.
|
10 minutes
|
The effect of vibrotactile stimulation on gait
Time Frame: 10 minutes
|
Time to complete the timed up and go task will be investigated, comparing stimulation 10% above step frequency/10% below step frequency/sham
|
10 minutes
|
The effect of vibrotactile stimulation on freezing
Time Frame: 10 minutes
|
Number of freezing episodes during the timed up and go task will be investigated, comparing stimulation 10% above step frequency/10% below step frequency/sham
|
10 minutes
|
Investigating the effect of vibrotactile stimulation at tremor frequency on tremor severity in 3 different contexts
Time Frame: 25 minutes
|
The investigators will explore the change in log transformed tremor power from baseline to stimulation as a function of stimulation setting (bursts at tremor frequency/bursts at 1.5 times tremor frequency) and context (rest/posture/cognitive coactivation).
|
25 minutes
|
Investigating the effect of continuous stimulation on tremor severity in 3 different contexts
Time Frame: 25 minutes
|
The investigators will explore the change in log transformed tremor power from baseline to stimulation, as a function of stimulation setting (continuous 80Hz stimulation vs. sham) and context (rest/posture/cognitive coactivation).
|
25 minutes
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL77202.091.21
- 2021-12968 (Other Identifier: Commissie Mensgebonden Onderzoek)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Vibrotactile stimulation at tremor frequency
-
KU LeuvenCompleted
-
KU LeuvenCompleted
-
University of Colorado, DenverRecruiting
-
Marquette UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingStroke | Proprioceptive DisordersUnited States
-
Stanford UniversityJohn A Blume FoundationCompleted
-
Stanford UniversitySuspendedLow Back Pain | Chronic Pain | Migraine | Pelvic Pain | Functional Abdominal Pain SyndromeUnited States
-
University of ChicagoMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's DiseaseUnited States
-
University of MinnesotaRecruiting
-
Neurovoxel SLPCompleted